Why Older Individuals Need the COVID-19 Booster Shot

Translate to Spanish or other 102 languages!

The CDC is now recommending booster shots for certain populations who previously received the Pfizer vaccine. This includes adults who are 65 years and older. Image for illustration purposes.

Mega Doctor News

- Advertisement -

CLEVELAND – The CDC is now recommending booster shots for certain populations who previously received the Pfizer vaccine. This includes adults who are 65 years and older.

Ardeshir Hashmi, MD, Section Chief of geriatrics for Cleveland Clinic, said this age group is more vulnerable to the virus.

“People who are older who do get COVID, they have more likelihood of being hospitalized and also increased risk of mortality. 80% of the COVID deaths that we’re seeing are all above the age of 65. So as much protection as you can get to shore up those defenses, the better,” said Dr. Hashmi.

- Advertisement -

He said while the vaccine is effective, immunity can wane over time – which is why the booster shot is recommended.

It’s important to note that only those who received both doses of the Pfizer vaccine are eligible at the moment. And their last shot had to have been at least six months ago.

Moderna and Johnson and Johnson are not offering booster shots at this time. However, that is expected to change in the near future.

Dr. Hashmi encourages everyone to get the booster shot if they qualify, especially with the highly contagious Delta variant circulating.

- Advertisement -

“The Delta variant is more contagious and also very, very impactful in terms of mortality and hospitalizations and just severity of illness. The symptoms can be quite profound,” he said.

Dr. Hashmi said older individuals should also continue to take other safety precautions, like wearing a mask, regularly washing their hands and practicing social distancing. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

DHR Health Expands Ophthalmology Services with Addition of Dr. Rachel Gelman

 Continuing its mission to provide exceptional medical care to patients across the Rio Grande Valley, DHR Health is pleased to welcome ophthalmologist Dr. Rachel Gelman to its team of healthcare providers.

STHS McAllen Welcomes Aspiring Youth for an Interactive Look Inside Healthcare

As the demand for healthcare professionals continues to grow, introducing young students to the wide range of opportunities available in the medical field is more important than ever. From nurses and physicians to emergency responders, pharmacists and other essential healthcare workers, each plays a critical role in caring for patients and keeping communities healthy.

South Texas Health System Invests $25,000 in VIDA to Expand Healthcare Career Opportunities in the RGV

To help address the ongoing need for qualified workers in the Rio Grande Valley, South Texas Health System (STHS) has renewed its support of Valley Initiative for Development and Advancement (VIDA) through a $25,000 annual grant.
- Advertisement -